Kestra Medical Technologies, Ltd. (KMTS) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $19.74. It has a SharesGrow Score of 49/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
Analyst consensus target is KMTS = $28 (+41.8% upside).
Valuation: KMTS trades at a trailing Price-to-Earnings (P/E) of -6.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.1.
Financials: revenue is $60M, +189.8%/yr average growth. Net income is $114M (loss), growing at -59.9%/yr. Net profit margin is -190.3% (negative). Gross margin is 40.5% (+180.1 pp trend).
Balance sheet: total debt is $44M against $205M equity (Debt-to-Equity (D/E) ratio 0.22, conservative). Current ratio is 6.72 (strong liquidity). Debt-to-assets is 15%. Total assets: $296M.
Analyst outlook: 3 / 4 analysts rate KMTS as buy (75%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 71/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 55/100 (Partial), Future 85/100 (Pass), Income 10/100 (Fail).
